May 28, 2024
Abbott agrees to consent decree with FDA, could restart plant within 2 weeks, pending court approval

Abbott agrees to consent decree with FDA, could restart plant within 2 weeks, pending court approval

If a court approves the agreement, the company says it could restart the site within two weeks. It would first resume the production of its specialty metabolic formulas EleCare and Alimentum, followed by Similac and other formulas.

After Abbott restarts the site, it will take six to eight weeks for the products to reach store shelves, it said.

This is a developing story and will be updated.

Source link